| scholarly article | Q13442814 |
| P50 | author | Samuel I. Stupp | Q7411769 |
| Melina R. Kibbe | Q88593303 | ||
| P2093 | author name string | Joseph E Saavedra | |
| Larry K Keefer | |||
| Qun Jiang | |||
| Janet Martinez | |||
| Jozef Murar | |||
| Muneera R Kapadia | |||
| Nick D Tsihlis | |||
| Sadaf S Ahanchi | |||
| Daniel A Popowich | |||
| Lesley W Chow | |||
| Joseph A Hrabie | |||
| James F Hulvat | |||
| Jason W Eng | |||
| P2860 | cites work | Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide | Q29619956 |
| Presentation of RGDS epitopes on self-assembled nanofibers of branched peptide amphiphiles | Q30483707 | ||
| Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. | Q34158412 | ||
| Selective differentiation of neural progenitor cells by high-epitope density nanofibers | Q34291910 | ||
| Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery | Q34316431 | ||
| Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor | Q34404949 | ||
| Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells | Q34573717 | ||
| Chemistry of the nitric oxide-releasing diazeniumdiolate ("nitrosohydroxylamine") functional group and its oxygen-substituted derivatives | Q34593735 | ||
| Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q34595917 | ||
| Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates | Q34988094 | ||
| Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors | Q35750041 | ||
| Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide | Q35767797 | ||
| Nitric oxide: an endogenous modulator of leukocyte adhesion | Q37519420 | ||
| Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation | Q38552623 | ||
| Nitric oxide: a physiologic messenger molecule | Q40394921 | ||
| Polymeric-based perivascular delivery of a nitric oxide donor inhibits intimal thickening after balloon denudation arterial injury: role of nuclear factor-kappaB. | Q41719642 | ||
| Gene inhibition and gene augmentation for the treatment of vascular proliferative disorders | Q41744299 | ||
| Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery | Q42454758 | ||
| Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis | Q42547800 | ||
| Self-assembling peptide amphiphile nanofiber matrices for cell entrapment | Q42802041 | ||
| Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo | Q43610465 | ||
| Local infusion of the nitric oxide donor Sin-1 after angioplasty. Effects on intimal hyperplasia in porcine coronary arteries | Q44503754 | ||
| Stent-based nitric oxide delivery reducing neointimal proliferation in a porcine carotid overstretch injury model | Q45272295 | ||
| Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs | Q45889196 | ||
| Nitric oxide-generating hydrogels inhibit neointima formation | Q46587705 | ||
| Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts | Q48019037 | ||
| Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. | Q50927284 | ||
| Mechanisms of stenosis after arterial injury. | Q50927765 | ||
| Modulation of fluorescence through coassembly of molecules in organic nanostructures. | Q51085441 | ||
| Heparin binding nanostructures to promote growth of blood vessels. | Q51134148 | ||
| Localized delivery of nitric oxide from hydrogels inhibits neointima formation in a rat carotid balloon injury model. | Q51201621 | ||
| Branched peptide-amphiphiles as self-assembling coatings for tissue engineering scaffolds. | Q51224740 | ||
| The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty | Q58010013 | ||
| Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia | Q64379705 | ||
| Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate | Q64380720 | ||
| Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats | Q64382103 | ||
| Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium | Q69908131 | ||
| L-arginine inhibits balloon catheter-induced intimal hyperplasia | Q70742086 | ||
| Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury | Q70934724 | ||
| Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine | Q72170728 | ||
| Pathobiology of intimal hyperplasia | Q72787481 | ||
| cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway | Q73120319 | ||
| Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty | Q73233083 | ||
| Conversion of a polysaccharide to nitric oxide-releasing form. Dual-mechanism anticoagulant activity of diazeniumdiolated heparin | Q73715152 | ||
| L-arginine polymers inhibit the development of vein graft neointimal hyperplasia | Q73813774 | ||
| Oral administration of L-arginine reduces intimal hyperplasia in balloon-injured rat carotid arteries | Q74587825 | ||
| Local delivery of nitric oxide from an eluting stent to inhibit neointimal thickening in a porcine coronary injury model | Q77996345 | ||
| Direct measurement of nitric oxide and oxygen partitioning into liposomes and low density lipoprotein | Q81229914 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P921 | main subject | nanotechnology | Q11468 |
| P304 | page(s) | 173-182 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Journal of Vascular Surgery | Q15755733 |
| P1476 | title | Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia | |
| P478 | volume | 47 |
| Q36030131 | A Peptide-Based Material for Therapeutic Carbon Monoxide Delivery |
| Q33948616 | Advances and prospect of nanotechnology in stem cells |
| Q36584904 | Analytical chemistry of nitric oxide |
| Q50528049 | Anti-DNA antibody modified coronary stent for plasmid gene delivery: results obtained from a porcine coronary stent model. |
| Q28394837 | Assessing nanotoxicity in cells in vitro |
| Q59032489 | Biological, Chemical, and Electronic Applications of Nanofibers |
| Q37180665 | Co-assembling peptides as defined matrices for endothelial cells |
| Q39322467 | Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response |
| Q37304690 | Development of cardiovascular bypass grafts: endothelialization and applications of nanotechnology |
| Q30428613 | Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas |
| Q38638945 | Drug delivery by supramolecular design. |
| Q35796515 | Drug release from hydrazone-containing peptide amphiphiles |
| Q37350497 | Dynamic in vivo biocompatibility of angiogenic peptide amphiphile nanofibers |
| Q34762218 | Effect of nitric oxide on neointimal hyperplasia based on sex and hormone status |
| Q36912476 | Emerging peptide nanomedicine to regenerate tissues and organs |
| Q35947546 | Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing |
| Q37679100 | Fibrillar peptide gels in biotechnology and biomedicine |
| Q38001430 | Functionalized nanostructures with application in regenerative medicine |
| Q37038730 | Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome |
| Q41874552 | Inhibitory Effect of Ginsenoside Rg1 on Vascular Smooth Muscle Cell Proliferation Induced by PDGF-BB Is Involved in Nitric Oxide Formation |
| Q35058371 | Insights into the effect of nitric oxide and its metabolites nitrite and nitrate at inhibiting neointimal hyperplasia |
| Q34150577 | Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes |
| Q33814725 | Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injury |
| Q36421859 | Long-term effect of PROLI/NO on cellular proliferation and phenotype after arterial injury. |
| Q33693549 | Modular self-assembling biomaterials for directing cellular responses |
| Q39869953 | Multi-composite bioactive osteogenic sponges featuring mesenchymal stem cells, platelet-rich plasma, nanoporous silicon enclosures, and Peptide amphiphiles for rapid bone regeneration |
| Q35176430 | Nanocarriers for nitric oxide delivery |
| Q90184613 | Nanomatrix Coated Stent Enhances Endothelialization but Reduces Platelet, Smooth Muscle Cell, and Monocyte Adhesion under Physiologic Conditions |
| Q36366440 | Nanostructure-templated control of drug release from peptide amphiphile nanofiber gels |
| Q36625450 | Nitric oxide delivery via a permeable balloon catheter inhibits neointimal growth after arterial injury. |
| Q37661426 | Nitric oxide differentially affects ERK and Akt in type 1 and type 2 diabetic rats |
| Q35159280 | Nitric oxide increases lysine 48-linked ubiquitination following arterial injury. |
| Q83745461 | Nitric oxide inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by increasing the ubiquitination and degradation of UbcH10 |
| Q37424144 | Nitric oxide is less effective at inhibiting neointimal hyperplasia in spontaneously hypertensive rats. |
| Q36966244 | Nitric oxide may inhibit neointimal hyperplasia by decreasing isopeptidase T levels and activity in the vasculature |
| Q35926097 | Nitric oxide release: part II. Therapeutic applications |
| Q37887771 | Nitric oxide: a guardian for vascular grafts? |
| Q36546557 | Omega-3 Status and the Relationship between Plasma Asymmetric Dimethylarginine and Risk of Myocardial Infarction in Patients with Suspected Coronary Artery Disease |
| Q35026955 | Peptide Amphiphile Nanofiber Delivery of Sonic Hedgehog Protein to Reduce Smooth Muscle Apoptosis in the Penis After Cavernous Nerve Resection |
| Q35573162 | Peptide Self-Assembly for Crafting Functional Biological Materials |
| Q48133884 | Peptide-Functionalized Fluorescent Particles for In Situ Detection of Nitric Oxide via Peroxynitrite-Mediated Nitration. |
| Q45016507 | Peptide-based hydrogen sulphide-releasing gels. |
| Q34519394 | Periadventitial atRA citrate-based polyester membranes reduce neointimal hyperplasia and restenosis after carotid injury in rats |
| Q37018499 | Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery |
| Q48313522 | Phenotypic switching prevention and proliferation/migration inhibition of vascular smooth muscle cells by the ruthenium nitrosyl complex trans-[Ru(NO)Cl(cyclam](PF6 )2. |
| Q33796974 | Poly(diol-co-citrate)s as novel elastomeric perivascular wraps for the reduction of neointimal hyperplasia |
| Q33951477 | Polymer-Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications |
| Q35179026 | Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery |
| Q38241490 | Recent developments in the effects of nitric oxide-donating statins on cardiovascular disease through regulation of tetrahydrobiopterin and nitric oxide |
| Q33917189 | Regulation of reactive oxygen species by p53: implications for nitric oxide-mediated apoptosis |
| Q39074623 | Role of Nanotechnology in Erectile Dysfunction Treatment |
| Q37567611 | Role of metabolic environment on nitric oxide mediated inhibition of neointimal hyperplasia in type 1 and type 2 diabetes |
| Q37809501 | Self-assembled gels for biomedical applications. |
| Q35968451 | Self-assembling peptide scaffolds for regenerative medicine |
| Q35772871 | Shape-Dependent Targeting of Injured Blood Vessels by Peptide Amphiphile Supramolecular Nanostructures |
| Q37579963 | Supramolecular Nanofibers of Peptide Amphiphiles for Medicine |
| Q38092061 | Surface modification of implanted cardiovascular metal stents: from antithrombosis and antirestenosis to endothelialization |
| Q36661502 | Targeted Nitric Oxide Delivery by Supramolecular Nanofibers for the Prevention of Restenosis After Arterial Injury |
| Q90833282 | Targeted delivery of nitric oxide via a 'bump-and-hole'-based enzyme-prodrug pair |
| Q35039014 | The protective effect of Bcl-xl overexpression against oxidative stress-induced vascular endothelial cell injury and the role of the Akt/eNOS pathway |
| Q38014981 | Therapeutic strategies to combat neointimal hyperplasia in vascular grafts. |
Search more.